Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ru Feng

Showing results (511-520 of 540) with videos related to

Pageof 54
Sort By:
NPJ Dementia|December 22, 2025
Integrated genomic analysis and CRISPRi implicates <i>EGFR</i> in Alzheimer's disease riskYuk Yee Leung, Pavel P Kuksa, Luke Carter, et al.
Pharmacological Research|November 15, 2025
Parishin A reduces hepatic encephalopathy via gut microbiota increasing the activity of intestinal EAAT3 to reduce blood ammoniaJin-Yue Lu, Heng-Tong Zuo, Ru Feng, et al.
Thrombosis Research|February 27, 2016
Increased prostacyclin levels inhibit the aggregation and activation of platelets via the PI3K-AKT pathway in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantationXiao-Hui Zhang, Shi-Yuan Zhou, Ru Feng, et al.
Oncotarget|June 25, 2016
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction modelWen-Yang Liu, Nicola Dinapoli, Xin Wang, et al.
Annals of Hematology|June 18, 2024
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINEKeshu Zhou, Tingyu Wang, Ling Pan, et al.
Annals of Hematology|February 4, 2026
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match studyYun Wang, Xiaoqin Chen, Qi Liang, et al.
Environment International|October 8, 2021
Associations between both legacy and alternative per- and polyfluoroalkyl substances and glucose-homeostasis: The Isomers of C8 health project in ChinaYun-Ting Zhang, Mohammed Zeeshan, Fan Su, et al.
Experimental Hematology & Oncology|June 17, 2026
Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinomaShan-Ru Feng, En-Fu Dong, Zheng Gao, et al.
BMC Cancer|July 28, 2016
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Yongping Song, Liping Su, et al.
Nature Cancer|April 28, 2022
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competitionJiang Li, Yingying Ye, Zhihan Liu, et al.
Pageof 54

Showing results (511-520 of 540) with videos related to

Sort By:
Pageof 54
NPJ Dementia|December 22, 2025
Integrated genomic analysis and CRISPRi implicates <i>EGFR</i> in Alzheimer's disease riskYuk Yee Leung, Pavel P Kuksa, Luke Carter, et al.
Pharmacological Research|November 15, 2025
Parishin A reduces hepatic encephalopathy via gut microbiota increasing the activity of intestinal EAAT3 to reduce blood ammoniaJin-Yue Lu, Heng-Tong Zuo, Ru Feng, et al.
Thrombosis Research|February 27, 2016
Increased prostacyclin levels inhibit the aggregation and activation of platelets via the PI3K-AKT pathway in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantationXiao-Hui Zhang, Shi-Yuan Zhou, Ru Feng, et al.
Oncotarget|June 25, 2016
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction modelWen-Yang Liu, Nicola Dinapoli, Xin Wang, et al.
Annals of Hematology|June 18, 2024
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINEKeshu Zhou, Tingyu Wang, Ling Pan, et al.
Annals of Hematology|February 4, 2026
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match studyYun Wang, Xiaoqin Chen, Qi Liang, et al.
Environment International|October 8, 2021
Associations between both legacy and alternative per- and polyfluoroalkyl substances and glucose-homeostasis: The Isomers of C8 health project in ChinaYun-Ting Zhang, Mohammed Zeeshan, Fan Su, et al.
Experimental Hematology & Oncology|June 17, 2026
Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinomaShan-Ru Feng, En-Fu Dong, Zheng Gao, et al.
BMC Cancer|July 28, 2016
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Yongping Song, Liping Su, et al.
Nature Cancer|April 28, 2022
Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competitionJiang Li, Yingying Ye, Zhihan Liu, et al.
Pageof 54